Home
Company
Leadership
Board of Directors
Therapeutics
Rivoceranib
Apealea
®
Expanded Access Program
News
Press Releases
Publications
Events
Careers
Contact Us
Search
Home
Company
Leadership
Board of Directors
Therapeutics
Rivoceranib
Apealea
®
Expanded Access Program
News
Press Releases
Publications
Events
Careers
Contact Us
Search
Home
Company
Leadership
Board of Directors
Therapeutics
Rivoceranib
Apealea
®
Expanded Access Program
News
Press Releases
Publications
Events
Careers
Contact Us
Publications
Gynecologic Oncology: Phase 3 Publication of Efficacy & Safety Results Comparing Paclitaxel Micellar & Cremophor EL-Paclitaxel
ASCO Annual Meeting 2020 Poster Report of Rivoceranib in Recurrent or Metastatic Adenoid Cystic Carcinoma
ASCO-SITC Clinical Immuno-Oncology Symposium 2019 Poster Report of Rivoceranib in Combination with Nivolumab
AACR 2018 Poster Report of Preclinical Rivoceranib (Apatinib) Combination with Immunotherapy
ACCP 2017 Poster of a Phase 1 Ethnic PK Study
ASCO 2017 Poster Report of Apatinib Phase III Trial in Progress
ESMO 2016 Poster Report of Apatinib Phase II Study Results